Editas Medicine, Inc. short interest in 2022
In 2022, Editas Medicine, Inc.'s disclosed short interest ran from 16.56% of shares outstanding on 14 Jan 2022 to 31.48% on 30 Dec 2022, a change of +14.92 percentage points. The year's high was 31.48% on 30 Dec 2022 and its low 16.04% on 31 Jan 2022, averaging 22.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.48 days on 14 Oct 2022. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 16.56% (14 Jan 2022)
- End of year
- 31.48% (30 Dec 2022)
- Change
- +14.92 pp
- High
- 31.48% (30 Dec 2022)
- Low
- 16.04% (31 Jan 2022)
- Average
- 22.54%
- Highest days to cover
- 14.48 (14 Oct 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 16.56% | 6.27 | |
| 31 Jan 2022 | 16.04% | 4.49 | |
| 15 Feb 2022 | 16.22% | 5.54 | |
| 28 Feb 2022 | 16.71% | 6.80 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 17.25% | 6.67 | |
| 31 Mar 2022 | 17.94% | 6.71 | |
| 14 Apr 2022 | 18.25% | 9.61 | |
| 29 Apr 2022 | 18.38% | 7.49 | |
| 13 May 2022 | 19.07% | 6.40 | 10-Q filed, results (8-K) |
| 31 May 2022 | 21.03% | 10.29 | |
| 15 Jun 2022 | 21.30% | 11.16 | |
| 30 Jun 2022 | 22.30% | 6.36 | |
| 15 Jul 2022 | 23.86% | 9.37 | |
| 29 Jul 2022 | 24.40% | 10.02 | |
| 15 Aug 2022 | 23.64% | 9.31 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 24.26% | 10.83 | |
| 15 Sep 2022 | 25.07% | 10.80 | |
| 30 Sep 2022 | 26.41% | 10.44 | |
| 14 Oct 2022 | 26.98% | 14.48 | |
| 31 Oct 2022 | 26.86% | 13.38 | |
| 15 Nov 2022 | 27.48% | 12.57 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 28.58% | 9.72 | |
| 15 Dec 2022 | 30.79% | 9.98 | |
| 30 Dec 2022 | 31.48% | 10.29 |
See also: Editas Medicine, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.